Fast and sensitive detection of viable <i>Escherichia coli</i> O157:H7 using a microwell-confined and propidium monoazide-assisted digital CRISPR microfluidic platform.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39228336.
- Also identified by DOI 10.1039/d4lc00672k.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<i>Escherichia coli</i> O157:H7 is a major foodborne pathogen that poses a significant threat to food safety and human health. Rapid and sensitive detection of viable <i>Escherichia coli</i> O157:H7 can effectively prevent food poisoning. Here, we developed a microwell-confined and propidium monoazide-assisted digital CRISPR microfluidic platform for rapid and sensitive detection of viable <i>Escherichia coli</i> O157:H7 in food samples. The reaction time is significantly reduced by minimizing the microwell volume, yielding qualitative results in 5 min and absolute quantitative results in 15 min. With the assistance of propidium monoazide, this platform can eliminate the interference from 99% of dead <i>Escherichia coli</i> O157:H7. The direct lysis method obviates the need for a complex nucleic acid extraction process, offering a limit of detection of 3.6 × 10<sup>1</sup> CFU mL<sup>-1</sup> within 30 min. Our results demonstrated that the platform provides a powerful tool for rapid detection of <i>Escherichia coli</i> O157:H7 and provides reliable guidance for food safety testing.
Medical subject headings
- Escherichia coli O157
- Azides
- Propidium